1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor

Haemostasis
M MuhmK Lechner

Abstract

1-Deamino-8-D-arginine vasopressin (DDAVP) was administered to 3 patients with spontaneous factor VIII inhibitors. In 2 patients with baseline factor VIII levels above 1%, a marked increase of factor VIII activity after DDAVP infusion could be observed. No rise of factor VIII activity after DDAVP was seen in the 3rd patient with a baseline factor VIII level of less than 1%. Daily infusion of DDAVP resulted in a reduction of the efficacy, but the full effect could be retained when DDAVP was given at 48-hour intervals. The effect of DDAVP infusion on factor VIII levels in the 2 responding patients was superior to the treatment with 30 U/kg factor VIII concentrate and approximately equivalent to infusion of 45 U/kg factor VIII concentrate. DDAVP may be a useful and less expensive treatment for patients with acquired factor VIII inhibitors and a baseline factor VIII level of more than 1%.

Citations

Nov 27, 1998·The American Journal of Medicine·P BossiR Zittoun
Jun 10, 2010·BMC Research Notes·Peter CollinsHervé Lévesque
Apr 27, 2012·Mediterranean Journal of Hematology and Infectious Diseases·Galila Zaher, Soheir Adam
Aug 1, 1993·American Journal of Hematology·R Mudad, W H Kane
Mar 22, 2001·Haemophilia : the Official Journal of the World Federation of Hemophilia·J J Puetz, J D Bouhasin
Mar 8, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·Nathan L KobrinskyD Sjolander
Jul 1, 2010·Pediatric Blood & Cancer·Massimo FranchiniGiuseppe Lippi
Jun 12, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·F BaudoF de Cataldo
Jul 1, 1990·Baillière's Clinical Haematology·A S Gallus
Aug 29, 2014·The Cochrane Database of Systematic Reviews·Yan ZengSongtao Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.